Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trialRaches Ella, Siddhartha Dutta, Sagar Vivek Redkar et al.|The Lancet|2021Cited by 361
Prevalence of hypertension among Indian adults: Results from the great India blood pressure surveySivasubramanian Ramakrishnan, Geevar Zachariah, Kartik Gupta et al.|Indian Heart Journal|2019Cited by 208
Laboratory surveillance for SARS-CoV-2 in IndiaPriya Abraham, Naveen S Yadav, Neeraj Aggarwal et al.|The Indian Journal of Medical Research|2020Cited by 81
Efficacy, safety, and lot to lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): a, double-blind, randomised, controlled phase 3 trialRaches Ella, Siddarth Reddy, William C. Blackwelder et al.|medRxiv|2021Cited by 80
SARS CoV-2 variant B.1.617.1 is highly pathogenic in hamsters than B.1 variantPragya D. Yadav, Balram Bhargava, Sreelekshmy Mohandas et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 60